Partnering to create custom-made medicine
A tailor-made suit sewn to fit a customer’s exact measurements almost always fits better than one purchased “off the rack.”
Researchers at MD Anderson are applying this same logic to cancer medicine, where tumors from patients with difficult-to-treat cancers are individually analyzed, then drugs and other therapies are prescribed to attack each tumor’s one-of-a-kind genetic and molecular makeup.
To demonstrate that this...
Treatment decisions traced back to diagnosing urologists
New research from MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in determining whether older...
Making prostate brachytherapy less of a shot in the dark
When Steven Frank, M.D., tackled a decades-old problem plaguing the field of prostate brachytherapy, he found himself in unchartered waters...
Breast reconstruction rates increase following mastectomies
Women who underwent a mastectomy as part of their treatment for breast cancer are increasingly opting for reconstructive surgery, according to new research published in the Journal of Clinical Oncology.
The observational study, led by MD Anderson and The University of Michigan, evaluated insurance claims from 20,506 women from 1998-2007 and found a nearly 20 percent increase in breast reconstruction. The research also noted...
Expressive writing reduces cancer-related symptoms and improves quality of life
In the largest expressive writing trial conducted on an oncology population, researchers from MD Anderson found those patients who recorded...
Details emerge in link between body mass index, chemotherapy response
MD Anderson researchers discussed new data on the connection between body mass index (BMI) and response to presurgical chemotherapy in patients...
Head and neck cancer patients have varied risks for second malignancies
MD Anderson-led research published in the journal Cancer is shedding light on the risk of second primary malignancies, a leading cause of...
Brain cancer: Cognition and quality of life important factors
In a large national, cooperative trial led by MD Anderson, researchers determined bevacizumab (Avastin), did not offer survival benefit to...
MD Anderson physician receives award for decades of accomplishments
Fifty years from now when an author is compiling a review of modern cancer therapy for a historical publication, he'll undoubtedly recognize...
Researchers develop tool to predict benefit of radiation therapy
During the next two decades, breast cancer diagnoses in older women are expected to increase by 57%. It's a reality that highlights the importance...